Suppr超能文献

乳腺肿瘤大小的准确估计:超声、乳腺X线摄影、磁共振成像及相关影响因素的比较

Accurate Estimation of Breast Tumor Size: A Comparison Between Ultrasonography, Mammography, Magnetic Resonance Imaging, and Associated Contributing Factors.

作者信息

Azhdeh Shilan, Kaviani Ahmad, Sadighi Nahid, Rahmani Maryam

机构信息

Department of Radiology, Tehran University of Medical Science, Tehran, Iran.

Department of Surgery, Tehran University of Medical Science, Tehran, Iran.

出版信息

Eur J Breast Health. 2020 Dec 24;17(1):53-61. doi: 10.4274/ejbh.2020.5888. eCollection 2021 Jan.

Abstract

OBJECTIVE

This study aimed to provide further evidence on the accuracy of tumor size estimates and influencing factors.

MATERIALS AND METHODS

In this cross-sectional study, patients with a biopsy-proven diagnosis of breast cancer referred to our hospital to obtain a preoperative magnetic resonance imaging (MRI) between 2015 and 2016 were included. Data from 76 breast cancer patients with 84 lesions were collected. All participants underwent ultrasonography and MRI, and their mammograms (MGMs) were reevaluated for tumor size estimation. Measurements by the three imaging modalities were compared with the pathologically determined tumor size to assess their accuracy. Influencing factors such as surgical management, molecular and histopathological subtypes, and Breast Imaging Reporting and Data System enhancement types in MRI were also assessed.

RESULTS

The rates of concordance with the gold standard were 64.3%, 76.2%, and 82.1% for MGM, ultrasound (US), and MRI measurements, respectively. Therefore, the highest concordance rate was observed in MRI-based estimates. Among the discordant cases, US and MGM underestimation were more prevalent (70%); nevertheless, MRI showed significant overestimation (80%). Tumor size estimates in patients whose MRIs presented with either non-mass enhancement [p=0.030; odds ratio (OR)=17.2; 95% confidence interval (CI): 1.3-225.9] or mass lesion with non-mass enhancement (p=0.001; OR=51.0; 95% CI: 5.0-518.4) were more likely to be discordant with pathological measurements compared with those in cases with only mass lesion on their MRIs.

CONCLUSION

MRI was more accurate than either US or MGM in estimating breast tumor size but had the highest overestimation rate. Therefore, caution should be practiced in interpreting data obtained from subjects whose MRIs present with non-mass enhancement or mass lesion with non-mass enhancement.

摘要

目的

本研究旨在为肿瘤大小估计的准确性及其影响因素提供更多证据。

材料与方法

在这项横断面研究中,纳入了2015年至2016年间转诊至我院进行术前磁共振成像(MRI)且经活检证实患有乳腺癌的患者。收集了76例乳腺癌患者84个病灶的数据。所有参与者均接受了超声检查和MRI检查,并对其乳房X线照片(MGM)进行重新评估以估计肿瘤大小。将三种成像方式的测量结果与病理确定的肿瘤大小进行比较,以评估其准确性。还评估了手术管理、分子和组织病理学亚型以及MRI中的乳腺影像报告和数据系统强化类型等影响因素。

结果

MGM、超声(US)和MRI测量与金标准的一致性率分别为64.3%、76.2%和82.1%。因此,基于MRI的估计一致性率最高。在不一致的病例中(70%),超声和MGM低估更为普遍;然而,MRI显示出明显的高估(80%)。与MRI仅显示肿块病变的病例相比,MRI表现为非肿块强化(p=0.030;比值比(OR)=17.2;95%置信区间(CI):1.3-225.9)或伴有非肿块强化的肿块病变(p=0.001;OR=51.0;95%CI:5.0-518.4)的患者,其肿瘤大小估计与病理测量结果不一致的可能性更大。

结论

在估计乳腺肿瘤大小方面,MRI比超声或MGM更准确,但高估率最高。因此,在解释MRI表现为非肿块强化或伴有非肿块强化的肿块病变的受试者的数据时应谨慎。

相似文献

2
Clinical accuracy of preoperative breast MRI for breast cancer.术前乳腺MRI对乳腺癌的临床诊断准确性
J Surg Oncol. 2017 Jun;115(8):924-931. doi: 10.1002/jso.24616. Epub 2017 Apr 13.

引用本文的文献

10
The Accuracy of Breast Cancer Diagnostic Tools.乳腺癌诊断工具的准确性。
Cureus. 2024 Jan 7;16(1):e51776. doi: 10.7759/cureus.51776. eCollection 2024 Jan.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验